Health

BOMBSHELL: Biogen's Alzheimer’s Drug Fails to Impress in Mixed Results!

Biogen's mid-stage study on tau-targeting Alzheimer's drug reveals disappointing outcomes, raising concerns for patients.

1 source covering this story